Siriuspoint LTD 8-K filings

SiriusPoint Ltd. announced a net income of $69 million for the second quarter of 2026, demonstrating solid financial performance and strategic progress.

SiriusPoint Ltd. reports results from its 2026 Annual General Meeting, including director elections, executive compensation approval, auditor appointment, and share plan adoption.

SiriusPoint Ltd. announced a net income of $100 million for the first quarter of 2026, demonstrating strong operational performance and a return on equity of 17.4%.

SiriusPoint Ltd. announced a settlement agreement with former SiriusPoint International CEO Rob Gibbs, detailing severance and post-employment obligations.

SiriusPoint Ltd. announced a new four-division business structure and the departure of Rob Gibbs, President & CEO of SiriusPoint International, as part of its ongoing evolution.

SiriusPoint's subsidiary, International Medical Group, will acquire global travel insurance brand World Nomads, expanding its distribution and enhancing financial metrics.

SiriusPoint Ltd. announced the completion of its previously disclosed sale of its entire equity stake in Arcadian Holdings Limited for $140 million in cash.

SiriusPoint Ltd. announced the full redemption of all 8 million of its 8.00% Resettable Fixed Rate Preference Shares, Series B, on February 26, 2026.

SiriusPoint Ltd. announced the completion of the sale of its supplemental health insurance program manager, ArmadaCorp Capital, to Ambac Financial Group Inc. for $250 million in cash.

SiriusPoint Ltd. announced robust third-quarter 2025 results, featuring strong underwriting performance, significant premium growth, and strategic MGA disposals set to enhance shareholder value.

SiriusPoint Ltd. announces the resignation of its Chief Accounting Officer, Evan Cabat, effective October 31, 2025, with CFO Jim McKinney assuming principal accounting officer duties.

SiriusPoint Ltd. announced the sale of its 49% equity stake in managing general agent Arcadian Risk Capital to Lee Equity Partners for $139 million, while extending its capacity agreement until 2031.

SiriusPoint announced the sale of its supplemental health insurance program manager, ArmadaCare, for $250 million, expecting a significant pre-tax gain and a 10% increase in tangible book value.

SiriusPoint Ltd. announced the appointment of Martin Hudson, an experienced (re)insurance leader, to its Board of Directors, effective September 1, 2025.

SiriusPoint Ltd. has adopted a new Executive Severance Plan, effective August 1, 2025, providing structured severance benefits to eligible employees upon certain terminations.

SiriusPoint Ltd. reported a significant increase in second-quarter core underwriting income and strong premium growth, driving a 120% rise in underlying earnings per share.

SiriusPoint Ltd.'s subsidiary, Sirius International Corporate Member Limited, has entered into a $35 million Tier 1 FAL Facility Agreement with Lloyds Bank PLC to provide collateral for its Lloyds of London Syndicate 1945.

SiriusPoint Ltd. held its 2025 annual general meeting where shareholders elected two Class III directors, approved executive compensation, and ratified the appointment of PricewaterhouseCoopers LLP as the independent auditor.

SiriusPoint Ltd. announces its first quarter 2025 results, highlighting continued underwriting profitability and a solid return on equity despite catastrophe losses.

SiriusPoint finalized the repurchase of shares from CM Bermuda and a secondary offering by entities linked to Daniel S. Loeb, marking a significant step in the company's strategic repositioning.

SiriusPoint announces its ninth consecutive quarter of underwriting profits, with a full-year Core combined ratio of 91.0% and significant progress in strategic reshaping.

SiriusPoint's Audit Committee has approved a $0.50 per share quarterly cash dividend on its Series B Preference Shares.

SiriusPoint will repurchase all common shares and warrants held by CM Bermuda for approximately $733 million, eliminating CM Bermuda's ownership stake and board representation.

SiriusPoint Ltd. has entered into a $400 million senior unsecured revolving credit facility to support working capital and general corporate purposes.

SiriusPoint Ltd. has appointed Meng Tee Saw to its Board of Directors, effective October 30, 2024, to fill a vacancy and serve as a Class I director.

SiriusPoint announced its third quarter results, highlighting an eighth consecutive quarter of underwriting profits and a seventh consecutive quarter of positive net income, despite impacts from a CMIG shareholder transaction.

SiriusPoint Ltd. has amended its previous 8-K filing to include the committee assignments for newly appointed board member Susan Cross.

SiriusPoint reported its seventh consecutive quarter of underwriting profits, a strong net income of $109.9 million, and announced a significant share repurchase program and a dividend on its Series B preference shares.

SiriusPoint Ltd. has appointed Susan Cross, a seasoned (re)insurance executive, to its Board of Directors, increasing the board size to ten members.

SiriusPoint Ltd. has announced the appointment of James J. McKinney as its new Chief Financial Officer, effective June 3, 2024, replacing Steve Yendall.